1993
DOI: 10.1128/aac.37.11.2506
|View full text |Cite
|
Sign up to set email alerts
|

Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin

Abstract: Vancomycin in combination with ciprofloxacin exhibited synergy against 7 of 10 strains of Pseudomonas aeruginosa. MICs for the microbial strains used in this study ranged from 0.0325 to 3.0 micrograms/ml for ciprofloxacin and from 23.5 to > 188 micrograms/ml for vancomycin. Combinations of these antibiotics, tested in a checkerboard pattern, gave fractional inhibitory concentrations of 0.5 or less for 7 of the 10 strains tested.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
8
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 16 publications
2
8
0
Order By: Relevance
“…This phenomenon has been reported for P . aeruginosa when exposed to different antibiotics, including treatment with CIP (Day et al ., ; Lee et al ., ).…”
Section: Resultsmentioning
confidence: 97%
“…This phenomenon has been reported for P . aeruginosa when exposed to different antibiotics, including treatment with CIP (Day et al ., ; Lee et al ., ).…”
Section: Resultsmentioning
confidence: 97%
“…In vitro data used to examine aminoglycoside-quinolone combinations also show variation, with some isolates demonstrating synergism and others showing indifference and, in some cases, antagonism [38,41]. There is also in vitro evidence of synergy when ciprofloxacin is combined with vancomycin [42]. However, to our knowledge, there are no data to examine the effectiveness of these combination in humans.…”
Section: Discussionmentioning
confidence: 92%
“…We then explored whether lysozyme-sensitive mutants also exhibited elevated sensitivity to antibiotic treatments. To examine bacterial responsiveness to antibiotics of diverse classes, we tested vancomycin (Day et al, 1993 ), ceftazidime (O'Callaghan, 1986 ), ampicillin (Ghobashy and Chiori, 1984 ), tobramycin (Hoff et al, 1974 ), and ciprofloxacin (Roy et al, 1983 ), the first three of which target cell wall synthesis. Tobramycin and ciprofloxacin inhibit protein synthesis and DNA replication, respectively.…”
Section: Resultsmentioning
confidence: 99%